Established nearly four decades ago, Wockhardt Limited today is among India's top reasearch and technology oriented pharmaceutical companies, with global presence. Wockhardt has emerged as a leading player in domestic as well as international markets, with widely accepted and efficacious drugs and formulations. The company has developed leading brands in Anti-infectives, Pain & Inflammation, Cough, Psychiatry, Medical nutrition and Biotechnology segments. The company's production facilities are situated in India, the United States, the United Kingdom, Ireland and France.
Wockhardt has an active multi-disciplinary R&D programme involving over 300 scientists, largely focused on developing innovative technologies and New Drug Discovery. The company has a team of over 90 scientists engaged in new drug discovery research and has several new chemical entities in the field of sepsis and anti-infectives.